Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 58 of 58 entries
View as:

Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole

Phase: N/A Priority: Normal
NCT ID: NCT01259115 Org: User:
Start: 10/31/02 End: 06/30/03 Due: 06/30/04

Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain

Phase: N/A Priority: Normal
NCT ID: NCT01324544 Org: User:
Start: 11/30/11 End: 08/31/14 Due: 08/31/15

The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.

Phase: N/A Priority: Normal
NCT ID: NCT00315445 Org: User:
Start: 12/31/97 End: 05/31/98 Due: 05/31/99

A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01100086 Org: User:
Start: 01/31/07 End: 06/30/07 Due: 06/30/08

A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01100320 Org: User:
Start: 01/31/07 End: 07/31/07 Due: 07/31/08

Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain

Phase: N/A Priority: Normal
NCT ID: NCT00365898 Org: User:
Start: 07/31/05 End: 07/31/05 Due: 07/31/06

Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.

Phase: N/A Priority: Normal
NCT ID: NCT00315458 Org: User:
Start: 12/31/03 End: 03/31/05 Due: 03/31/06

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01148537 Org: User:
Start: 07/31/04 End: 12/31/04 Due: 12/31/05